Brain lipid composition in postnatal iron-induced motor behavior alterations following chronic neuroleptic administration in mice

FEBS Journal

Volumn 273, Issue 10, 2006, Pages 2232-2243

  Isaac, Giorgis ^a,c   Fredriksson, Anders ^b   Danielsson, Rolf ^a   Eriksson, Per ^b   Bergquist, Jonas ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KANSAS STATE UNIVERSITY   (United States)

Author keywords

Neurodegenerative and psychiatric disorders; Neuroleptics; Phosphatidylcholine; Postnatal iron treatment; Sphingomyelin

Indexed keywords

CLOZAPINE; HALOPERIDOL; IRON; LIPID; NEUROLEPTIC AGENT; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ELECTROSPRAY MASS SPECTROMETRY; EXTRACTION; FEMALE; FRAGMENTATION REACTION; LIPID ANALYSIS; LIPID COMPOSITION; LIQUID CHROMATOGRAPHY; LOCOMOTION; MENTAL DISEASE; MOTOR ACTIVITY; MOTOR DYSFUNCTION; MOUSE; NEWBORN; NONHUMAN; PERINATAL PERIOD; POSTNATAL CARE; PRIORITY JOURNAL; REARING;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; BRAIN CHEMISTRY; CLOZAPINE; DIETARY SUPPLEMENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HALOPERIDOL; IRON; MEMBRANE LIPIDS; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PHOSPHATIDYLCHOLINES; PREGNANCY; SPHINGOMYELINS;

ANIMALIA;

EID: 33646259713     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2006.05236.x     Document Type: Article

References (66)

1. Brouwers JFHM Gadella BM van Golde LMG Tielens AGM 1998 Quantitative analysis of phosphatidylcholine molecular species using HPLC and light scattering detection J Lipid Res 39 344 353
2. Mano N Oda Y Yamada K Asakawa N Katayama K 1997 Simultaneous quantitative determination method for sphingolipid metabolites by liquid chromatography/ionspray ionization tandem mass spectrometry Anal Biochem 244 291 300
3. Murphy RC Fiedler J Hevko J 2001 Analysis of nonvolatile lipids by mass spectrometry Chem Rev 101 479 526
4. Fenton WS Hibbeln J Knable M 2000 Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia Biol Psychiatry 47 8 21
5. Feldberg W 1976 Possible association of schizophrenia with a disturbance in prostaglandin metabolism: a physiological hypothesis Psychiatry Med 6 359 369
6. Horrobin DF 1977 Schizophrenia as a prostaglandin deficiency disease Lancet 1 936 937
7. Horrobin DF 1998 The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia Schizophr Res 30 193 208
8. Horrobin DF Glen AIM Vaddadi K 1994 The membrane hypothesis of schizophrenia Schizophr Res 13 195 207
9. Horrobin DF Manku MS Hillman H Iain A Glen M 1991 Fatty acid levels in the brains of schizophrenics and normal controls Biol Psychiatry 30 795 805
10. Ross BM 2003 Phospholipid and eicosanoid signaling disturbances in schizophrenia Prostaglandins Leukot Essent Fatty Acids 69 407 412
11. Yao JK Van Kammen DP 2004 Membrane phospholipids and cytokine interaction in schizophrenia Int Rev Neurobiol 59 297 326
12. Connor JR Pavlick G Karli D Menzies SL Palmer C 1995 A histochemical study of iron-positive cells in the developing rat brain J Comp Neurol 355 111 123
13. Youdim MB Ben-Shachar D Riederer P 1991 Iron in brain function and dysfunction with emphasis on Parkinson's disease Eur Neurol 31 34 40
14. Ben-Shachar D Pinhassi B Youdim MB 1991 Prevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment Eur J Pharmacol 202 177 183
15. Ben-Shachar D Youdim MB 1991 Intranigral iron injection induces behavioural and biochemical parkinsonism in rats J Neurochem 57 2133 2135
16. Evans PH 1993 Free radicals in brain metabolism and pathology Br Med Bull 49 577 587
17. Olanow CW Cohen G Perl DP Marsden CD 1992 Role of iron and oxidation stress in the normal and parkinsonian brain Ann Neurol 32 S1 S145
18. Strong R Mattamal M Andorn A 1993 Free Radicals in Aging In Free Radicals, the Aging Brain, and Age-Related Neurodegenerative Disorders CRC Press Boca Raton, FL, USA
19. Dexter DT Carayon A Javoy-Agid F Agid Y Wells FR Daniel SE Lees AJ Jenner P Marsden CD 1991 Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia Brain 114 1953 1975
20. Kienzl E Puchinger L Jellinger K Linert W Stachelberger H Jameson RF 1995 The role of transition metals in the pathogenesis of Parkinson's disease J Neuro Sci 134 Suppl. 69 78
21. Reichmann H Janetzky B Riederer P 1995 Iron-dependent enzymes in Parkinson's disease J Neural Transm Supplement 46 157 164
22. Swaiman KF 1991 Hallervorden-Spatz syndrome and brain iron metabolism Arch Neurol 48 1285 1293
23. Dexter DT Holley AE Flitter WD Slater TF Wells FR Daniel SE Lees AJ Jenner P & MC 1994 Increased level of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study Mov Disord 9 92 97
24. Dexter DT Wells FR Agid F Agid Y Lees AJ Jenner P Marsden CD 1987 Increased nigral iron content in postmortem parkinsonian brain (letters) Lancet 2 1219 1220
25. Drayer BP Olanow W Burger P Johanson GA Herfkens R Riederer S 1986 Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron Radiology 159 493 498
26. Rustin P von Kleist-Retzow JC Munnich A 1998 Iron overload and mitochondrial diseases Lancet 351 1286 1287
27. Fredriksson A Schroder N Archer T 2003 Neurobehavioural deficits following postnatal iron overload. I. Spontaneous motor activity Neurotoxicity Res 5 53 76
28. Fredriksson A Schroder N Eriksson P Izquierdo I Archer T 2001 Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits Parkinsonism Relat Disord 7 97 105
29. Fredriksson A Schroder N Eriksson P Izquierdo I Archer T 2000 Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period Brain Res Dev Brain Res 119 65 74
30. Fredriksson A Schroder N Eriksson P Izquierdo I Archer T 1999 Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice Toxicol Appl Pharmacol 159 25 30
31. Schroder N Fredriksson A Vianna M Roesler R Izquierdo I Archer T 2001 Memory deficits in adult rats following postnatal iron administration Behav Brain Res 124 77 85
32. Singh SP Shankar R 1996 Effect of haloperidol on phospholipid biosythesis in rat brain Indian J Exp Biol 34 111 114
33. Iqbal MM Raham A Husain Z Mahmud SZ Ryan WR Feldman JM 2003 Clozapine: a clinical review of adverse effects and management Ann Clin Psychiatry 15 33 48
34. Schmitt A Wilczek K Blennow K Maras A Jatzko A Petroianu G Braus DF Gattaz WF 2004 Altered thalamic membrane phospholipids in schizophrenias: a postmortem study Biol Psychiatry 56 41 45
35. Yao JK Leonard S Reddy RD 2000 Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients Schizophr Res 42 7 17
36. Yao JK Stanley JA Reddy RD Keshavan MS Pettegrew JW 2002 Correlation between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites Biol Psychiatry 52 823 830
37. Schmitt A Maras A Petroianu G Braus DF Scheuer L Gattaz WF 2001 Effect of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia J Neural Transm General Sect 108 1081 1091
38. Fukuzako H Fukuzako T Kodama S Hashiguchi T Takigawa M Fujimoto T 1999 Haloperidol improves membrane phospholipi abnormalities in temporal lobes of schizophrenic patients Neuropsychopharmacology 21 542 549
39. Jensen JE Al-Semaan YM Williamson PC Neufeld RWJ Menson RS Schaeffer B Densmore M Drost DJ 2002 Regional-specific changes in phospholipid metabolism in chronic, medicated shizophrenia: 31P-MRS study at 4.0 Tesla Br J Psychiatry 180 39 44
40. 31P magnetic resonance spectroscopy: a preliminary study Psychiatry Res Neuroimaging 106 171 180
41. 31P-magnetic resonance spectroscopic study Biol Psychiatry 45 1221 1225
42. Hsu FF Bohrer A Turk J 1998 Formation of lithiated adducts of glycerophosphocholine lipids facilitates their identification by electrospray ionization tandem mass spectrometry J Am Soc Mass Spectrom 9 516 526
43. Kim HY Wang TC Ma YC 1994 Liquid chromatography/mass spectrometry of phospholipids using electrospray ionization Anal Chem 66 3977 3982
44. Olsson NU Salem N Jr. 1997 Molecular species analysis of phospholipids J Chromatogr B 692 245 256
45. Isaac G Bylund D Månsson J-E Markides KE Bergquist J 2003 Analysis of phosphatidycholine and sphingomyelin molecular species from brain extracts using capillary liquid chromatography electrospray ionization mass spectrometry J Neurosci Meth 128 111 119
46. Karlsson AA Michelsen P Odham G 1998 Molecular species of sphingomyelin: determination by high-performance liquid chromatography/mass spectrometry with electrospray and high-performance liquid chromatography/tandem mass spectrometry with atmospheric pressure chemical ionization J Mass Spectrom 33 1192 1198
47. Berger GE Wood SJ Pantelis C Velakoulis D Wellard RM McGory PD 2001 Implication of lipid biology for the pathogenesis of schizophrenia Aus NZ J Psychiatry 35 355 366
48. Lagarde M Geloen A Record M Vance D Spener F 2003 Lipidomics is emerging Biochim Biophys Acta 1634 61 61
49. Piomelli D 2005 The challenge of brain lipidomics Prostaglandins 77 23 34
50. Spener F Lagarde M Record M 2003 What is lipidomic? Eur J Lipid Sci Technol 105 481 482
51. Han X Gross RW 2003 Global analysis of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics J Lipid Res 44 1071 1079
52. Taylor EM & ME 1990 Developmental changes in transferrin and iron uptake by the brain in the rat Brain Res Dev Brain Res 55 35 42
53. Taylor EM Crowe A Morgan EH 1991 Transferrin and iron uptake by the brain: effects of altered iron status J Neurochem 57 1584 1592
54. Dwork AJ Lawler G Zybert PA Durkin M Osman M Willson N Barkai AI 1990 An autoradiographic study of the uptake and distribution of iron by the brain of the young rat Brain Res 518 31 39
55. Davison AN Dobbing J 1968 Applied Neurochemistry Blackwell Oxford, UK
56. Rozenzweig MR Leiman AL Breedlove SM 1999 Biological Psychology: an Introduction to Behavioral, Cognitive and Clinical Neuroscience Sinauer Assoc, Inc Sunderland, MA, USA
57. Bolles RG Woods PJ 1964 The ontogeny of behaviour in the albino rat Anim Behav 12 427 441
58. Campbell BA Lytle LD Fibiger HC 1969 Ontogeny of adrenergic arousal and cholinergic inhibitory mechanisms in the rat Science 166 635 637
59. Ben-Shachar D Livne E Spanier I Zuk R Youdim MB 1993 Iron modulates neuroleptic-induced effects related to the dopaminergic system Isr J Med Sci 29 587 592
60. Ben-Shachar D Youdim MB 1990 Neuroleptic-induced supersensitivity and brain iron. I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivity J Neurochem 54 1136 1141
61. Gattaz WF Schmitt A Maras A 1995 Increased platelet phospholipase A2 activity in schizophrenia Schizophr Res 16 1 6
62. Ross BM Hudson C Erlich J Warsh JJ Kish SJ 1997 Increased phospholipid breakdown in schizophrenia Arch General Psychiatry 54 487 494
63. Trzeciak HI Kalacinski W Malecki A Kokot D 1995 Effect of neuroleptics on phospholipase A2 activity in the brain of rats Eur Arch Psychiatry Clin Neurosci 245 179 182
64. Dalla Libera A Scutari G Boscolo R Rigobello MP Bindoli A 1998 Antioxidant properties of clozapine and related neuroleptics Free Radic Res 29 151 157
65. Sawas AH Gilbert JC 1985 Lipid peroxidation as a possible mechanism for the neurotoxic and nephrotoxic effect of a combination of lithium carbonate and haloperidol Arch Int Pharmacody Ther 276 301 312
66. Archer T Fredriksson A Jonsson G Lewander T Mohammed A Ross S Soderberg U 1986 Central noradrenaline depletion antagonizes aspects of d -amphetamine-induced hyperactivity in the rat Psychopharmacology 88 141 146